Stamford, CT -- (SBWIRE) -- 10/19/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Stocks In The Market Report - Groupon Inc (NASDAQ:GRPN), Polycom Inc (NASDAQ:PLCM), Nektar Therapeutics (NASDAQ:NKTR)
Groupon Inc (NASDAQ:GRPN) traded on volume of 28,540,732 shares in the last session against average volume of 23.39 million shares. The company started its trading session with the price of $11.35 and closed at $10.67 by scoring -6.77%. Groupon, Inc. operates as a local commerce marketplace that connects merchants to consumers by offering goods and services at a discount in North America and internationally.
Why Should Investors Buy GRPN After the Recent Fall? http://www.jetlifepennystocks.com/market-scan/?symbol=GRPN
Polycom Inc (NASDAQ:PLCM) started its last trading session with the price of $10.75 and closed at $10.78 by scoring +0.09%. The stock traded with total volume of 3,174,077 shares, while the average trading volume remained 2.62 million shares. The beta value of this stock stands at 0.98. Day range for the stock was $10.70 - $10.83. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration. The company offers video, voice, and content-management and content-sharing solutions.
Why Should Investors Buy PLCM After The Recent Gain? http://www.jetlifepennystocks.com/market-scan/?symbol=PLCM
Nektar Therapeutics (NASDAQ:NKTR) opened its last trade at the price of $10.13. Its closing price was $10.61 after gaining 4.53% for the day. The company traded with the total volume of 1,393,314 shares, while its average trading volume remained 1.63 million shares. The beta of this stock stands at 0.57. Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its product pipeline consists of drug candidates in various therapeutic areas, including oncology, pain, anti-infectives, and immunology.
For How Long NKTR will Fight for Profitability? http://www.jetlifepennystocks.com/market-scan/?symbol=NKTR
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)